SUBSCRIBE
SUBSCRIBE

Bitterroot Bio

NEWS
Map of NextGen Class of 2024/BioSpace
Business
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.
January 3, 2024
 · 
20 min read
 · 
BioSpace Editorial Staff
Pictured: Jar of money / Adobe Stock, juliasudnits
Bitterroot Launches with $145M Series A to Advance Cardio-Immuno Therapies
The start-up’s lead program, BRB-002, is designed to target the CD47/SIRPα pathway and the underlying causes of vascular inflammation and atherosclerosis.
June 8, 2023
 · 
2 min read
 · 
Tristan Manalac
IN THE PRESS
Press Releases
Bitterroot Bio Completes Enrollment in Phase 1 First-in-Human Study of BRB-002 in Healthy Volunteers
October 29, 2024
 · 
1 min read
Business
Bitterroot Bio Announces Appointment of Georgette Verdin as Chief People Officer and Sherwin Chen as Chief Legal Officer and Corporate Secretary
June 4, 2024
 · 
3 min read
Drug Development
Bitterroot Bio Announces Dosing of First Participants in a Phase 1, First-in-Human Study of BRB-002 in Healthy Volunteers
April 29, 2024
 · 
2 min read
Business
Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology
February 26, 2024
 · 
2 min read
Drug Development
Bitterroot Bio to Present Preclinical Research at American Heart Association Conference
October 30, 2023
 · 
1 min read
AWARDS
  • NextGen Badge - Brighspot Rework_NextGen - Class of 2024.jpg
JOBS